Manufacturer of Controlled Substances; Notice of Application; Noramco, Inc.

Federal Register, Volume 77 Issue 218 (Friday, November 9, 2012)

Federal Register Volume 77, Number 218 (Friday, November 9, 2012)

Notices

Page 67397

From the Federal Register Online via the Government Printing Office www.gpo.gov

FR Doc No: 2012-27394

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application; Noramco, Inc.

Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on July 9, 2012, Noramco, Inc., 1440 Olympic Drive, Athens, Georgia 30601, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------

Drug Schedule

------------------------------------------------------------------------

Gamma Hydroxybutyric Acid (2010)........... I

Codeine-N-oxide (9053)..................... I

Dihydromorphine (9145)..................... I

Morphine-N-oxide (9307).................... I

Amphetamine (1100)......................... II

Methylphenidate (1724)..................... II

Codeine (9050) II Dihydrocodeine (9120).... II

Oxycodone (9143)........................... II

Hydromorphone (9150)....................... II

Hydrocodone (9193)......................... II

Morphine (9300)............................ II

Oripavine (9330)........................... II

Thebaine (9333)............................ II

Oxymorphone (9652)......................... II

Noroxymorphone (9668)...................... II

Alfentanil (9737).......................... II

Sufentanil (9740).......................... II

Carfentanil (9743)......................... II

Tapentadol (9780).......................... II

Fentanyl (9801)............................ II

------------------------------------------------------------------------

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than January 8, 2013.

Dated: November 1, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

FR Doc. 2012-27394 Filed 11-8-12; 8:45 am

BILLING CODE 4410-09-P